BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16772034)

  • 1. Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression.
    Pospisil H; Herrmann A; Butherus K; Pirson S; Reich JG; Kemmner W
    BMC Genomics; 2006 Jun; 7():148. PubMed ID: 16772034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of zinc-finger BED domain-containing 3 (Zbed3) as a novel Axin-interacting protein that activates Wnt/beta-catenin signaling.
    Chen T; Li M; Ding Y; Zhang LS; Xi Y; Pan WJ; Tao DL; Wang JY; Li L
    J Biol Chem; 2009 Mar; 284(11):6683-9. PubMed ID: 19141611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated action of CK1 isoforms in canonical Wnt signaling.
    Del Valle-Pérez B; Arqués O; Vinyoles M; de Herreros AG; Duñach M
    Mol Cell Biol; 2011 Jul; 31(14):2877-88. PubMed ID: 21606194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
    Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
    World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells.
    Yook JI; Li XY; Ota I; Hu C; Kim HS; Kim NH; Cha SY; Ryu JK; Choi YJ; Kim J; Fearon ER; Weiss SJ
    Nat Cell Biol; 2006 Dec; 8(12):1398-406. PubMed ID: 17072303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein receptor-related protein 5 (LRP5) expression in human osteoarthritic chondrocytes.
    Papathanasiou I; Malizos KN; Tsezou A
    J Orthop Res; 2010 Mar; 28(3):348-53. PubMed ID: 19810105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.
    Leal LF; Mermejo LM; Ramalho LZ; Martinelli CE; Yunes JA; Seidinger AL; Mastellaro MJ; Cardinalli IA; Brandalise SR; Moreira AC; Tone LG; Scrideli CA; Castro M; Antonini SR
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3106-14. PubMed ID: 21849527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the AXIN1 gene in advanced prostate cancer.
    Yardy GW; Bicknell DC; Wilding JL; Bartlett S; Liu Y; Winney B; Turner GD; Brewster SF; Bodmer WF
    Eur Urol; 2009 Sep; 56(3):486-94. PubMed ID: 18514389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway.
    Glass DA; Karsenty G
    Curr Top Dev Biol; 2006; 73():43-84. PubMed ID: 16782455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization.
    Chen Y; Hu Y; Lu K; Flannery JG; Ma JX
    J Biol Chem; 2007 Nov; 282(47):34420-8. PubMed ID: 17890782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caprin-2 enhances canonical Wnt signaling through regulating LRP5/6 phosphorylation.
    Ding Y; Xi Y; Chen T; Wang JY; Tao DL; Wu ZL; Li YP; Li C; Zeng R; Li L
    J Cell Biol; 2008 Sep; 182(5):865-72. PubMed ID: 18762581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
    Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNTs in the ovine uterus: potential regulation of periimplantation ovine conceptus development.
    Hayashi K; Burghardt RC; Bazer FW; Spencer TE
    Endocrinology; 2007 Jul; 148(7):3496-506. PubMed ID: 17431004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
    He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
    Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.
    Juhlin CC; Haglund F; Villablanca A; Forsberg L; Sandelin K; Bränström R; Larsson C; Höög A
    Int J Oncol; 2009 Feb; 34(2):481-92. PubMed ID: 19148484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The many ways of Wnt in cancer.
    Polakis P
    Curr Opin Genet Dev; 2007 Feb; 17(1):45-51. PubMed ID: 17208432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-catenin as a potential key target for tumor suppression.
    Fu Y; Zheng S; An N; Athanasopoulos T; Popplewell L; Liang A; Li K; Hu C; Zhu Y
    Int J Cancer; 2011 Oct; 129(7):1541-51. PubMed ID: 21455986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
    Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.